Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02734160 |
Title | A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Eli Lilly and Company |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | FRA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Honor Health Research Institute | Scottsdale | Arizona | 85258 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Sarah Cannon Research Institute SCRI | Nashville | Tennessee | 37203 | United States | Details | |
Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | United States | Details | |
Gustave Roussy | Villejuif Cedex | 94805 | France | Details | ||
Ospedale Policlinico Giambattista Rossi, Borgo Roma | Verona | 37134 | Italy | Details | ||
Samsung Medical Center | Seoul | Korea | 06351 | Korea, Republic of | Details | |
Seoul National University Hospital | Seoul | 03080 | Korea, Republic of | Details | ||
Hospital Universitari Vall d'Hebron | Barcelona | 08035 | Spain | Details | ||
Hospital Universitario 12 de Octubre | Madrid | 28041 | Spain | Details | ||
Hospital Madrid Norte Sanchinarro | Madrid | 28050 | Spain | Details |